ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CUE vs CNTN // DIVIDEND YIELD & FCF PAYOUT SAFETY

Cue Biopharma Inc. (NASDAQ) VS. Canton Strategic Holdings Inc. (NASDAQ) • 15-METRIC TALLY: CUE 1 — CNTN 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CUE VS. CNTN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CUE CNTN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -4.10% -30.90 CNTN /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -14.03% -9.87% -4.16 CNTN /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) 180.00% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 2/9 +2.00 CUE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 46.7 46.9 -0.20 CNTN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $151.6M $155.4M -$3.8M CNTN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CUE REV CNTN REV CUE GROSS % CNTN GROSS % CUE FCF CNTN FCF
FY 2025 $27.5M $56.3M — — -$21.9M -$16.1M
FY 2024 $9.3M $34.8M — — -$36.4M -$10.9M
FY 2023 $5.5M $26.5M — — -$40.0M -$7.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CUE // BETA —
CNTN // BETA —